Application of Nanocarrier-Based Targeted Drug Delivery in the Treatment of Liver Fibrosis and Vascular Diseases. Journal of Medicine and Life Sciences, [S. l.], v. 1, n. 2, p. 63–69, 2025. DOI: 10.71222/bc9c9s73. Disponível em: https://www.gbspress.com/index.php/JMLS/article/view/216. Acesso em: 10 apr. 2025.